Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2017 December;59(4) > Panminerva Medica 2017 December;59(4):302-7

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

REVIEW  


Panminerva Medica 2017 December;59(4):302-7

DOI: 10.23736/S0031-0808.16.03236-5

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis

Hong CHEN 1, Nan HU 2, Peng CHANG 1, Tao KANG 1, Song HAN 1, Yaoliang LU 1 , Maoquan LI 2

1 Department of General Surgery, Taicang Hospital Affiliated to Soochow University, Taicang, Jiangsu, China; 2 Department of Vascular Surgery, Shanghai Tenth People’s Hospital Affiliated to Tongji University, Shanghai, China


PDF  


INTRODUCTION: Hepatocellular carcinoma (HCC) is the fifth-most common cancer. Recent studies have demonstrated that there was a relationship between modified Glasgow prognostic score (mGPS) and survival of HCC. However, the results were inconsistent.
EVIDENCE ACQUISITION: The following databases were searched for relevant articles published until June 2016: PubMed; EMBASE; Web of Science and the China National Knowledge Infrastructure. The strength of association between mGPS and OS of HCC was estimated by pooled HRs with corresponding 95% CIs.
EVIDENCE SYNTHESIS: Seven studies with 2047 HCC patients were included in this meta-analysis. The mGPS was an independent marker of poor prognosis in patients with HCC (HR=2.21; 95% CI: 1.73-2.82; I2=51%). In the subgroup analysis of study design, both prospective studies (HR=1.68; 95% CI: 1.35-2.11; I2=0%) and retrospective studies (HR=2.64; 95% CI: 1.92-3.62; I2=39%) with higher mGPS had shorter OS. The patients with resectable HCC and high mGPS also showed shorter OS (HR=2.33; 95% CI: 1.65-3.29; I2=63%). In the subgroup analysis by sample size, both large sample size studies (HR=2.56; 95% CI: 1.50-4.38; I2=72%) and small sample size studies (HR=2.00; 95% CI: 1.62-2.48; I2=0%) showed the same results.
CONCLUSIONS: In conclusion, this meta-analysis suggested that mGPS might be an independent prognostic factor for HCC.


KEY WORDS: Carcinoma, hepatocellular - Meta-analysis as topic - Survival

inizio pagina

Publication History

Issue published online: November 8, 2017
Article first published online: December 21, 2016
Manuscript accepted: December 5, 2016
Manuscript revised: November 8, 2016
Manuscript received: July 17, 2016

Per citare questo articolo

Chen H, Hu N, Chang P, Kang T, Han S, Lu Y, et al. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis. Panminerva Med 2017;59:302-7. DOI: 10.23736/S0031-0808.16.03236-5

Corresponding author e-mail

luyaoliangdr@126.com